| All news from BASILEA PHARMACEUTICA AG |
|
|
|
|
|
|
|
| 2022 sales |
109M
111M
111M
|
| 2022 net income |
-26.8M
-27.3M
-27.3M
|
| Net debt 2022 |
47.8 million
48.6M
48.6M
|
| PER 2022 ratio |
-17.5x |
| 2022 return |
– |
|
| Capitalization |
456M
463M
463M
|
| EV / Sales 2022 |
4.62x |
| EV / Sales 2023 |
3.42x |
| # of employees |
177 |
| Floating |
88.1% |
|
| Chart BASILEA PHARMACEUTICA AG |
|
Duration :
Period :
|
 |
|
|
Trends in technical analysis BASILEA PHARMACEUTICA AG
|
Short term |
Middle term |
Long term |
| Tendencies |
Bearish |
Bullish |
Neutral |
Evolution of the income statement
|
|
| Medium consensus |
SURPASS |
| Number of analysts |
4 |
| Last closing price |
CHF38.50 |
| Average target price |
CHF67.48 |
| Average Spread / Target |
75.3% |
|
